Primary Site >> Stomach Cancer
Gene >> HLA-A
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: HLA antigens and Ia antibody in the gastric cancer patient. PMID: 905325 |
Ref: Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. PMID: 2672003 |
Ref: Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. PMID: 12845646 Ref: Induction of T lymphocytes specific to human gastric cancer using HLA-A matched allogeneic gastric tumor cells. PMID: 12973029 Ref: EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. PMID: 14679012 |
Ref: Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas. PMID: 16108831 |
Ref: Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. PMID: 16630140 Ref: Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. PMID: 16761627 |
Ref: Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response. PMID: 21165574 Ref: Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer. PMID: 21205089 |
Ref: Association of MHC class I expression and lymph node metastasis of gastric carcinoma. PMID: 23108078 Ref: The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer. PMID: 24244023 |
Ref: Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. PMID: 24398900 Ref: The translation elongation factor eEF2 is a novel tumorassociated antigen overexpressed in various types of cancers. PMID: 24589652 |